Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | EPHA2 |
| Upstream (Parents) |
|---|
| (<<) CD3EAP → EPHA2 |
| (<<) CDCP1 → EPHA2 |
| (<<) E2F6 → EPHA2 |
| (<<) FOSL1 → EPHA2 |
| (<<) PHLDA2 → EPHA2 |
| (<<) TTC9 → EPHA2 |
| (<<) YWHAQ → EPHA2 |
| Downstream (Children) |
|---|
| EPHA2 → ANKRD57 (>>) |
| EPHA2 → BCL2L1 (>>) |
| EPHA2 → DUSP5 (>>) |
| EPHA2 → ELOVL1 (>>) |
| EPHA2 → FAM48A (>>) |
| EPHA2 → HLA-DOA (>>) |
| EPHA2 → HOXA3 (>>) |
| EPHA2 → KLK10 (>>) |
| EPHA2 → PKIG (>>) |
| EPHA2 → SERPINB1 (>>) |
| EPHA2 → SERPINB5 (>>) |
| EPHA2 → TPM3 (>>) |
| EPHA2 → YRDC (>>) |
